| Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids T Yamazaki, M Nagashima, D Ninomiya, Y Arai, Y Teshima, A Fujimoto, ... Japanese journal of infectious diseases 64 (1), 40-49, 2011 | 29 | 2011 |
| Neutralizing antibodies induced by gene-based hydrodynamic injection have a therapeutic effect in lethal influenza infection T Yamazaki, M Nagashima, D Ninomiya, A Ainai, A Fujimoto, I Ichimonji, ... Frontiers in Immunology 9, 290629, 2018 | 18 | 2018 |
| Broadly neutralizing antibodies for influenza: passive immunotherapy and intranasal vaccination M Biswas, T Yamazaki, J Chiba, S Akashi-Takamura Vaccines 8 (3), 424, 2020 | 13 | 2020 |
| Receptor-destroying enzyme (RDE) from Vibrio cholerae modulates IgE activity and reduces the initiation of anaphylaxis T Yamazaki, M Inui, K Hiemori, S Tomono, M Itoh, I Ichimonji, ... Journal of Biological Chemistry 294 (17), 6659-6669, 2019 | 11 | 2019 |
| Neutralizing Anti-Hemagglutinin monoclonal antibodies induced by Gene-Based transfer have prophylactic and therapeutic effects on influenza virus infection T Yamazaki, J Chiba, S Akashi-Takamura Vaccines 6 (3), 35, 2018 | 10 | 2018 |
| A novel gene delivery vector of agonistic anti-radioprotective 105 expressed on cell membranes shows adjuvant effect for DNA immunization against influenza T Yamazaki, M Biswas, K Kosugi, M Nagashima, M Inui, S Tomono, ... Frontiers in Immunology 11, 606518, 2020 | 4 | 2020 |
| Cell surface expression of human RP105 depends on N‐glycosylation of MD‐1 M Biswas, T Yamazaki, S Tomono, S Karnan, H Takagi, I Ichimonji, M Inui, ... FEBS letters 596 (24), 3211-3231, 2022 | 2 | 2022 |
